While 17 countries have now achieved trachoma elimination status, there is still work to be done, with trachoma responsible for the blindness or visual impairment of about 1.9 million people worldwide. Collaborators are being invited to join a new research project aimed at assessing the drivers for ...

A new WWARN study involving a collaboration of 107 researchers has provided unique insights in the epidemiology of submicroscopic malaria in pregnancy.

The latest WWARN newsletter is out now. Read more about our part in a new consortium tackling malaria drug resistance in South-East Africa, which is led by Professor Karen Barnes, of the University of Cape Town.

We are very sad to share news of the death of Professor Dominic Kwiatkowski. He was the Director of the Centre for Genomics and Global Health, and held a joint position as MRC Clinical Research Professor at Oxford University, and as a Principal Investigator at the Wellcome Trust Sanger Institute.

A new study suggests that, although there is sparse evidence, substandard and falsified (SF*) antiretrovirals occur and enhanced surveillance is needed.

Matt Brack, IDDO’s Senior Programme Manager, recently presented on our equitable approach to data collaborations in global health research at the Consortium of Universities for Global Health Conference (CUGH) in Washington, DC.

Last month, experts in medicine quality and substandard and falsified (SF) medicines gathered in Oxford for an informal one-day meeting following the workshop ‘The relationship between substandard and falsified antimicrobials and antimicrobial resistance and patient outcomes’.

A new consortium MARC SE-Africa (Mitigating Antimalarial Resistance Consortium in Southern and East Africa) launches today, responding to a growing crisis in malaria, one of the greatest infectious challenges facing Africa.

The Infectious Diseases Data Observatory (IDDO) is delighted to announce that Dr James Watson has been appointed as the new Associate Director from March 2023.

A new WWARN study has found that nearly two-thirds of the malaria-positive patients who present to health facilities are systematically excluded from "classical" anti-malarial treatment efficacy trials.

We work with researchers in disease-affected communities to address their key priorities and improve patient outcomes. IDDO shares knowledge, delivers collaborative analyses, and ensures academic recognition for all data contributors. The World Economic Forum recently blogged on our work. "There are...

The three presentations and expert discussion, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available on our YouTube channel @IDDOandWWARN. You can watch the full, partially captioned event here. ...

Two new studies using WWARN-hosted clinical trial data show that the dosing of the 8-aminoquinoline drugs primaquine and tafenoquine can be substantially improved. These analyses include the majority of all studied vivax malaria patients who received 8-aminoquinoline drugs over the last 20 years. La...

Read more about what we’ve been up to in our latest newsletter. There are updates on our research across COVID-19, malaria, medicine quality, febrile illness, Visceral leishmaniasis and you can sign up for our February 3 webinar - Radical cure of vivax malaria: can we do better?

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Find out more about what we've been up to in our latest newsletter. You'll find all of our news including our recent collaborative meta-analysis, commissioned by the WHO, which informed a change to its guidelines for treating uncomplicated malaria in the first trimester of pregnancy.

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Two new studies using WWARN-hosted clinical trial data show that the dosing of the 8-aminoquinoline drugs primaquine and tafenoquine can be substantially improved. These analyses include the majority of all studied vivax malaria patients who received 8-aminoquinoline drugs over the last 20 years. La...

A new WWARN meta-analysis commissioned by the World Health Organization (WHO) which informed a change to its treatment guidelines* has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first ...

IDDO’s Director Professor Philippe Guérin has been awarded the ASTMH Distinguished International Fellow at this year’s conference in Seattle, USA.